XASXSIG
Market cap2.55bUSD
Dec 20, Last price
2.60AUD
1D
-1.14%
1Q
84.40%
Jan 2017
101.55%
Name
Sigma Healthcare Ltd
Chart & Performance
Profile
Sigma Healthcare Limited, together with its subsidiaries, engages in the wholesale and distribution of pharmaceutical products primarily in Australia. It operates approximately 1,200 branded and independent pharmacy stores under the Amcal, Discount Drug Stores, Guardian, WholeLife, and PharmaSave brands. The company also provides hospital pharmacy wholesale services; dose administration aid services to the aged care sector, community pharmacy sector, and in the home; technology solutions and data analytics; and product development and support for a range of private and exclusive label products, as well as supplies medical consumables and devices to a broad range of customers, including pharmacy aged care facilities, hospitals, and clinics. In addition, it offers contract logistics services to pharmaceutical manufacturers and other supplier partners. Sigma Healthcare Limited was founded in 1912 and is headquartered in Rowville, Australia.
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑01 | 2023‑01 | 2022‑01 | 2021‑01 | 2020‑01 | 2019‑01 | 2018‑01 | 2017‑01 | 2016‑01 | 2015‑01 | |
Income | ||||||||||
Revenues | 3,322,058 -9.24% | 3,660,240 6.21% | 3,446,164 1.35% | |||||||
Cost of revenue | 3,394,006 | 3,729,163 | 3,556,346 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | (71,948) | (68,923) | (110,182) | |||||||
NOPBT Margin | ||||||||||
Operating Taxes | 3,313 | 2,435 | (1,971) | |||||||
Tax Rate | ||||||||||
NOPAT | (75,261) | (71,358) | (108,211) | |||||||
Net income | 4,509 148.98% | 1,811 -125.02% | (7,239) -116.63% | |||||||
Dividends | (9,981) | (14,960) | (19,927) | |||||||
Dividend yield | 0.91% | 2.29% | 2.82% | |||||||
Proceeds from repurchase of equity | 396,117 | 879 | (165,000) | |||||||
BB yield | -36.17% | -0.13% | 23.35% | |||||||
Debt | ||||||||||
Debt current | 9,789 | 12,944 | 25,693 | |||||||
Long-term debt | 263,473 | 348,082 | 297,739 | |||||||
Deferred revenue | 134,041 | 132,739 | ||||||||
Other long-term liabilities | 7,179 | 4,909 | 4,150 | |||||||
Net debt | (96,856) | 326,993 | 273,872 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 41,965 | 142,738 | (46,280) | |||||||
CAPEX | (4,718) | (29,399) | (14,204) | |||||||
Cash from investing activities | 5,734 | (28,604) | (16,592) | |||||||
Cash from financing activities | 295,825 | (116,941) | 128,891 | |||||||
FCF | (24,536) | (8,239) | (162,231) | |||||||
Balance | ||||||||||
Cash | 356,496 | 16,650 | 31,145 | |||||||
Long term investments | 13,622 | 17,383 | 18,415 | |||||||
Excess cash | 204,015 | |||||||||
Stockholders' equity | 917,960 | 529,448 | 549,467 | |||||||
Invested Capital | 812,406 | 709,660 | 816,360 | |||||||
ROIC | ||||||||||
ROCE | ||||||||||
EV | ||||||||||
Common stock shares outstanding | 1,063,315 | 1,028,057 | 1,570,572 | |||||||
Price | 1.03 62.20% | 0.64 41.11% | 0.45 -31.82% | |||||||
Market cap | 1,095,214 67.77% | 652,816 -7.63% | 706,757 -31.82% | |||||||
EV | 1,000,199 | 981,657 | 982,219 | |||||||
EBITDA | (43,625) | (38,587) | (82,491) | |||||||
EV/EBITDA | ||||||||||
Interest | 16,303 | 14,407 | 10,841 | |||||||
Interest/NOPBT |